These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35018443)

  • 21. Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".
    Kokic Males V
    Diabetes Res Clin Pract; 2020 May; 163():108163. PubMed ID: 32333972
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'.
    Ghoshal S;
    Diabetes Metab Syndr; 2020; 14(5):1541. PubMed ID: 32947752
    [No Abstract]   [Full Text] [Related]  

  • 23. The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.
    McGovern AP; Thomas NJ; Vollmer SJ; Hattersley AT; Mateen BA; Dennis JM
    Diabetologia; 2021 May; 64(5):1184-1186. PubMed ID: 33594475
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter to the Editor: Mental Health and Psychological Distress in People with Diabetes during COVID-19.
    Mukhtar S; Mukhtar S
    Metabolism; 2020 Jul; 108():154248. PubMed ID: 32335075
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    Viola V; Leanza G; Tramontana F
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5271-e5272. PubMed ID: 34383045
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    Nogues X; Quesada-Gomez JM; Garcia-Giralt N
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5281-e5282. PubMed ID: 34331760
    [No Abstract]   [Full Text] [Related]  

  • 29. [Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"].
    Martins TGDS
    Acta Med Port; 2021 Jan; 34(1):63. PubMed ID: 33092689
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to Letter to the Editor from Speeckaert et al: "Vitamin D Deficiency Is Associated With Higher Hospitalisation Risk from COVID-19: A Retrospective Case-Control Study".
    Jude EB
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e442. PubMed ID: 34529783
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter to the Editor in response to article: Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis (Martha et al.).
    Siniorakis EE; Arvanitakis SG; Elkouris MJ
    Diabetes Metab Syndr; 2021; 15(3):1059-1060. PubMed ID: 33814294
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter to the editor RE: Lake et al., 2022 comment on Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.
    Anderson DA; Godfrey DI
    EBioMedicine; 2022 Mar; 77():103899. PubMed ID: 35278742
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter to the Editor in response to the article: "Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis" (Ghoshal et al.).
    Chand R; Asmil SH; Chico M
    Diabetes Metab Syndr; 2020; 14(5):1305. PubMed ID: 32755826
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter to the Editor: Acute Coronary Syndrome Trends and COVID-19 Waves (Response to the Letter of Čulić et al.).
    Sutherland N; Dayawansa N; Filipopoulos B; Vasanthakumar S; Narayan O; Ponnuthurai FA; van Gaal W
    Heart Lung Circ; 2022 Mar; 31(3):e34-e35. PubMed ID: 35033431
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.).
    Ekiz T; Kara M; Özçakar L
    Diabetes Metab Syndr; 2020; 14(4):525-526. PubMed ID: 32402930
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.
    Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P
    Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter to the Editor: Endocrine and diabetes clinical practice during national lockdown and post lockdown period.
    Panchangam RB; Kota SK; Mayilvaganan S
    Diabetes Metab Syndr; 2020; 14(4):479. PubMed ID: 32387866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.